Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity. JAMA Oncology
.png)
More help Strategy Provides a description of the approaches to the identification, screening and quality assessment of the data relevant to identification of the key events and key event relationships included in the AOP or AOP network.This information is important as a basis to support the objective/envisaged application of the AOP by the regulatory community and to facilitate the reuse of its components
10.1186/s12964-021-00732-z Cell Commun
In a clinical trial on 46 patients with non-small cell lung cancer, one group received chemotherapy alone (carboplatin [Paraplatin] plus vinorelbine [Navelbine] or gemcitabine [Gemzar]) and the other group received chemotherapy plus 2.5 grams of fish oil daily
US$ 25.07
US$ 25.49
US$ 21.97
